Immune Response to Influenza Vaccine in Pediatric Patients With Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 7, 2007, Pages 851-856

  Mamula, Petar ^a   Markowitz, Jonathan E ^b   Piccoli, David A ^a   Klimov, Alexander ^a   Cohen, Louis ^d   Baldassano, Robert N ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; INFLUENZA VACCINE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; COMMON COLD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ENTERITIS; FEMALE; FLU LIKE SYNDROME; HEADACHE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PAIN; PEDIATRICS; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SEROLOGY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; VACCINATION;

ADOLESCENT; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTININS; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34447098030     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.02.035     Document Type: Article

References (37)

1. Papadakis K.A., and Targan S.R. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am 28 (1999) 283-296
2. Korzenik J., and Dieckgraefe B. Is Crohn's disease an immunodeficiency?. A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 45 (2000) 1121-1129
3. Sands B.E., Cuffari C., Katz J., et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 10 (2004) 677-692
4. Kilhamn J., Brevinge H., Svennerholm A.M., et al. Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect Immun 66 (1998) 3995-3999
5. Brogan M.D., Shanahan F., Oliver M., et al. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol 24 (1987) 69-74
6. Stevens R., Oliver M., Brogan M., et al. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. Gastroenterology 88 (1985) 1860-1866
7. Tonnesmann E., Burkle P.A., Schafer B., et al. [The immune competence of patients with Crohn's disease (author's transl)]. Klin Wochenschr 57 (1979) 1097-1107
8. Nielsen H.J., Mortensen T., Holten-Andersen M., et al. Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Scand J Gastroenterol 36 (2001) 265-269
9. Sonnenberg A., Jacobsen S.J., and Wasserman I.H. Periodicity of hospital admissions for inflammatory bowel disease. Am J Gastroenterol 89 (1994) 847-851
10. Kangro H.O., Chong S.K., Hardiman A., et al. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 98 (1990) 549-553
11. Armstrong K.L., Fraser D.K., and Faoagali J.L. Gastrointestinal bleeding with influenza virus. Med J Aust 154 (1991) 180-182
12. Block S.L. Role of influenza vaccine for healthy children in the US. Paediatr Drugs 6 (2004) 199-209
13. Neuzil K.M., Mellen B.G., Wright P.F., et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000) 225-231
14. Harper S.A., Fukuda K., Uyeki T.M., et al., Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza. MMWR Recomm Rep 54 (2005) 1-40
15. Chalmers A., Scheifele D., Patterson C., et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 21 (1994) 1203-1206
16. Malleson P.N., Tekano J.L., Scheifele D.W., et al. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol 20 (1993) 1769-1773
17. Brydak L.B., Roszkowska-Blaim M., Machala M., et al. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 18 (2000) 3280-3286
18. Mauch T.J., Crouch N.A., Freese D.K., et al. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 127 (1995) 957-960
19. Briggs W.A., Rozek R.J., Migdal S.D., et al. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 92 (1980) 471-477
20. Gross P.A., Lee H., Wolff J.A., et al. Influenza immunization in immunosuppressed children. J Pediatr 92 (1978) 30-35
21. Versluis D.J., Beyer W.E., Masurel N., et al. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42 (1986) 376-379
22. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
23. Barnett E.D. Influenza immunization for children. N Engl J Med 338 (1998) 1459-1461
24. Palache A.M. Influenza vaccines. A reappraisal of their use. Drugs 54 (1997) 841-856
25. Stamboulian D., Bonvehi P.E., Nacinovich F.M., et al. Influenza. Infect Dis Clin North Am 14 (2000) 141-166
26. Kendal A.P., Pereira M.S., and Shekel J.J. Concepts and procedures for laboratory-based influenza surveillance (1982), Centers for Disease Control, Atlanta
27. Lichtiger S., Present D.H., Kornbluth A., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330 (1994) 1841-1845
28. Hyams J.S., Ferry G.D., Mandel F.S., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
29. Huang K.L., Armstrong J.A., and Ho M. Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun 40 (1983) 421-424
30. Dengler T.J., Strnad N., Buhring I., et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66 (1998) 1340-1347
31. Beyer W.E., Palache A.M., de Jong J.C., et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20 (2002) 1340-1353
32. Ruben F.L. Inactivated influenza virus vaccines in children. Clin Infect Dis 38 (2004) 678-688
33. Arora D., and Ross A.C. Antibody response against tetanus toxoid is enhanced by lipopolysaccharide or tumor necrosis factor-alpha in vitamin A-sufficient and deficient rats. Am J Clin Nutr 59 (1994) 922-928
34. Elkayam O., Caspi D., Reitblatt T., et al. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33 (2004) 283-288
35. Kapetanovic M.C., Saxne T., Sjoholm A., et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45 (2006) 106-111
36. Mow W.S., Abreu-Martin M.T., Papadakis K.A., et al. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol Hepatol 2 (2004) 309-313
37. Fomin I., Caspi D., Levy V., et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65 (2006) 191-194